Zoster recombinant (zoster vaccine recombinant)

Approved for SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles): • in adults aged 50 years and older. • in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy. Limitations of Use: • SHINGRIX is not indicated for prevention of primary varicella infection…

Loading full data from Know Your Drugs Institute…